According to IMARC Group’s latest report, titled “Regenerative Medicine Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025,”. Looking forward, IMARC Group expects the global regenerative medicine market to continue its strong growth during the next five years.
Regenerative medicine refers to a field of biomedical sciences involved in restoring the structure and function of damaged cells, organs, and tissues. It includes the study of stem cells that are developed in laboratories and then safely inserted into the human body to regenerate damaged bones, cartilage, blood vessels, and organs. Cellular and acellular regenerative medicines are widely adopted in various clinical therapeutic procedures, including cell therapies, immunomodulation, and tissue engineering. They have the potential to treat various chronic diseases, including Alzheimer’s, Parkinson’s, cardiovascular disorders (CVDs), osteoporosis, spinal cord injuries, etc.
Request for a free sample copy of this report: https://www.imarcgroup.com/regenerative-medicine-market/requestsample
The rising prevalence of chronic diseases and genetic disorders is primarily driving the demand for regenerative medicine across the globe. Moreover, the growing geriatric population who are more prone to musculoskeletal, dermatological, and cardiological disorders is also augmenting the need for regenerative medicines. Furthermore, several technological advancements in cell-based therapies have led to the adoption of 3D bioprinting techniques and artificial intelligence (AI), thereby further propelling the market for regenerative medicine. Moreover, regenerative medicine decreases the risk of organ rejection by the body post-transplant and increases the patient’s recovery speed, thereby gaining traction in numerous organ transplantation procedures. The increasing investments in extensive R&D activities in the field of medical sciences are expected to drive the market for regenerative medicine.
Regenerative Medicine Market 2020-2025 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Allergan PLC (AbbVie Inc.)
- Amgen Inc.
- Baxter International Inc.
- BD (Becton, Dickinson and Company)
- Integra Lifesciences Holdings Corporation
- Medtronic plc
- Mimedx Group Inc.
- Novartis AG
- Osiris Therapeutics Inc. (Smith & Nephew plc)
- Thermo Fisher Scientific Inc.
The report has segmented the market on the basis of type, application, end user and region.
Breakup by Type:
- Stem Cell Therapy
- Tissue Engineering
Breakup by Application:
- Bone Graft Substitutes
- Osteoarticular Diseases
- Central Nervous System
Breakup by End User:
- Specialty Clinics
Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://bit.ly/2RAf08Y
Breakup by Region:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: [email protected]
Follow us on twitter: @imarcglobal